You searched for "medicines"
Pioneering eye device restores reading vision to blind eyes
A pivotal European clinical trial of a new electronic eye implant has seen remarkable results. The study, published in the New England Journal of Medicine, showed 84% of participants were able to read letters, numbers and words using prosthetic vision...Glaucoma UK Fellow receives international research award
Dr Giovanni Montesano, the Glaucoma UK Pitts Crick Fellow, has been awarded an ARVO Foundation Early Career Clinician-Scientist Research Award in recognition of his outstanding work in vision research. The award celebrates early career clinician-scientists whose research is shaping the...The most memorable patient encounters and what they taught me
In ophthalmology, some encounters blend quietly into the rhythm of clinic. Others stay with us, shaping how we practice and who we become as clinicians. These moments become the unexpected teachers of our training. They are subtle yet leave a...The restorative prescription: The case for carbon-negative healthcare
The Hippocratic Oath begins with a simple, profound directive: ‘First, do no harm.’ Yet, for decades, the global healthcare sector has been locked in a quiet paradox. While doctors work tirelessly to treat illnesses, heat exhaustion and vector-borne diseases, the...The new 2023/24 Eye News Product Guide is here!
This compact A5-size product guide is packed with information on all of your latest products, bound together in one handy booklet, making this such a fantastic resource which the profession use throughout the year when looking to purchase new equipment or products.
Long-term outcome of ALPI for plateau iris syndrome
The purpose of this study was to evaluate the long-term outcomes of plateau iris syndrome (PIS) patients treated with argon laser peripheral iridoplasty (ALPI) following YAG laser peripheral iridotomy (LPI). Typical ALPI settings were a spot size of 200 to...My Top Five: Key insights from recent research into uveitis in adults
Uveitis, characterised by inflammation of the uvea – the eye’s middle layer comprising the iris, ciliary body, and choroid – remains a leading cause of visual impairment worldwide [1]. It primarily affects adults aged 20–50 years. Untreated uveitis may cause...
Steroid implants in the treatment of post-epiretinal membrane peel macular oedema
This is a retrospective review of 39 eyes of 37 patients treated with Ozurdex® (intravitreal dexamethasone implant) for persistent post-operative cystoid macular oedema (CMO) following vitrectomy and idiopathic epiretinal membrane (ERM) peeling. The 0.7mg implant was injected in each eye...
Multimodal imaging in wet AMD
This novel study set out to determine grader agreement levels of various retinal imaging techniques, commonly used in the diagnosis of wet age-related macular degeneration (AMD). Images from 52 eyes were by examined by two different observers. All images were...
Conservative vs surgical management outcomes for congenital fibrovascular pupillary membrane for young vs older children
The authors present the clinical characteristics and outcomes of different treatment methods for congenital fibrovascular pupillary membrane (CFPM). This was a retrospective case series from a single centre including 12 patients (13 eyes; 4 males, 8 females) over a 7-year...WE KNOW THAT YOU ARE MORE THAN MEETS THE EYE
Charity’s new campaign aims to dispel negative perceptions of people living with sight loss.
